ReviewTobacco control2006
Philip Morris's Project Sunrise: weakening tobacco control by working with it.
Review in Tobacco control, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
43 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The vector of the tobacco epidemic: tobacco industry practices in low and middle-income countries.Cancer causes & control : CCC · 2012Pooled it
- Intimidation against advocates and researchers in the tobacco, alcohol and ultra-processed food spaces: a review.Health promotion international · 2024Review
- [What does Harm Reduction in Tobacco Use means to Public Health].Revista espanola de salud publica · 2024Article
- Pharmaceuticalisation as the tobacco industry's endgame.BMJ global health · 2024Article
- The Perils of Partnership: Interactions Between Public Health England, Drinkaware, and the Portman Group Surrounding the Drink Free Days Campaign.International journal of health policy and management · 2024Article
- Influence of Disclosed and Undisclosed Funding Sources in Tobacco Harm Reduction Discourse: A Social Network Analysis.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2023Review
- Evidence use in E-cigarettes debates: scientific showdowns in a 'wild west' of research.BMC public health · 2021Article
- Role of procedural intervention and acute illness in veterans affairs smoking cessation program referrals: A retrospective study.Tobacco prevention & cessation · 2021Article
- Tobacco industry and public health responses to state and local efforts to end tobacco sales from 1969-2020.PloS one · 2020Article
- E-Cigarettes: A Disruptive Technology? An Analysis of Health Actors' Positions on E-Cigarette Regulation in Scotland.International journal of environmental research and public health · 2019Article
- Tobacco and electronic nicotine delivery systems regulation.Translational lung cancer research · 2019Review
- Transnational Tobacco Companies and New Nicotine Delivery Systems.American journal of public health · 2019Review
- Heated tobacco products: another tobacco industry global strategy to slow progress in tobacco control.Tobacco control · 2018Article
- Corporate practices and health: a framework and mechanisms.Globalization and health · 2018Review
- Potential deaths averted in USA by replacing cigarettes with e-cigarettes.Tobacco control · 2018Article
- Booze and butts: A content analysis of the presence of alcohol in tobacco industry's lifestyle magazines.Addictive behaviors reports · 2016Article
- 'Public enemy no. 1': Tobacco industry funding for the AIDS response.SAHARA J : journal of Social Aspects of HIV/AIDS Research Alliance · 2016Review
- "What Is Our Story?" Philip Morris's Changing Corporate Narrative.American journal of public health · 2015Article
- Old wine in new bottles: tobacco industry's submission to European Commission tobacco product directive public consultation.Health policy (Amsterdam, Netherlands) · 2015Article
- Seeking out 'easy targets'? Tobacco companies, health inequalities and public policy.Tobacco control · 2014Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
objectiveTo analyse the implications of Philip Morris USA's (PM's) overtures toward tobacco control and other public health organisations, 1995-2006. DATA SOURCES: Internal PM documents made available through multi-state US attorneys general lawsuits and other cases, and newspaper sources.
methodsDocuments were retrieved from several industry documents websites and analysed using a case study approach.
resultsPM's Project Sunrise, initiated in 1995 and proposed to continue through 2006, was a long-term plan to address tobacco industry delegitimisation and ensure the social acceptability of smoking and of the company itself. Project Sunrise laid out an explicit divide-and-conquer strategy against the tobacco control movement, proposing the establishment of relationships with PM-identified "moderate" tobacco control individuals and organisations and the marginalisation of others. PM planned to use "carefully orchestrated efforts" to exploit existing differences of opinion within tobacco control, weakening its opponents by working with them. PM also planned to thwart tobacco industry delegitimisation by repositioning itself as "responsible". We present evidence that these plans were implemented.
conclusionSunrise exposes differences within the tobacco control movement that should be further discussed. The goal should not be consensus, but a better understanding of tensions within the movement. As the successes of the last 25 years embolden advocates to think beyond passage of the next clean indoor air policy or funding of the next cessation programme, movement philosophical differences may become more important. If tobacco control advocates are not ready to address them, Project Sunrise suggests that Philip Morris is ready to exploit them.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.